X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Bliss GVS Pharma Ltd.
BSE CODE: 506197   |   NSE CODE: BLISSGVS   |   ISIN CODE : INE416D01022   |   30-Apr-2024 Hrs IST
BSE NSE
Rs. 123.70
-0.75 ( -0.6% )
 
Prev Close ( Rs.)
124.45
Open ( Rs.)
124.45
 
High ( Rs.)
131.10
Low ( Rs.)
120.75
 
Volume
55802
Week Avg.Volume
42957
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 123.60
-0.95 ( -0.76% )
 
Prev Close ( Rs.)
124.55
Open ( Rs.)
124.50
 
High ( Rs.)
131.00
Low ( Rs.)
120.30
 
Volume
1356702
Week Avg.Volume
723300
 
52 WK High-Low Range(Rs.)
70.85
149.6
Particulars Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operational & Financial Ratios          
   Earnings Per Share (Rs)8.21  8.94  6.54  8.95  7.22  
   CEPS(Rs)9.66  10.27  7.88  9.81  7.77  
   DPS(Rs)0.50  0.50  0.50  0.50  1.00  
   Book NAV/Share(Rs)89.11  81.16  72.31  66.21  58.49  
   Tax Rate(%)26.12  26.69  25.98  24.14  37.98  
Margin Ratios          
   Core EBITDA Margin(%)15.07  17.16  19.65  22.66  21.82  
   EBIT Margin(%)21.02  20.54  20.86  29.04  28.87  
   Pre Tax Margin(%)19.34  19.86  19.59  27.54  28.13  
   PAT Margin (%)14.29  14.56  14.50  20.89  17.45  
   Cash Profit Margin (%)16.82  16.74  17.46  22.89  18.80  
Performance Ratios          
   ROA(%)7.70  9.15  7.50  11.61  10.41  
   ROE(%)9.66  11.68  9.45  14.36  13.00  
   ROCE(%)12.89  14.68  12.02  17.75  18.80  
   Asset Turnover(x)0.54  0.63  0.52  0.56  0.60  
   Sales/Fixed Asset(x)1.83  2.65  2.25  2.99  4.82  
   Working Capital/Sales(x)1.04  1.06  0.88  0.85  0.88  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.55  0.38  0.44  0.33  0.21  
   Receivable days246.41  217.24  295.44  308.46  267.22  
   Inventory Days50.10  49.84  56.55  47.66  40.49  
   Payable days92.78  80.11  88.42  66.93  53.67  
Valuation Parameters          
   PER(x)8.68  8.61  15.08  11.26  24.94  
   PCE(x)7.37  7.49  12.53  10.28  23.15  
   Price/Book(x)0.80  0.95  1.37  1.52  3.08  
   Yield(%)0.70  0.65  0.51  0.50  0.56  
   EV/Net Sales(x)1.23  1.15  2.12  2.36  4.30  
   EV/Core EBITDA(x)5.21  5.17  8.91  7.59  14.23  
   EV/EBIT(x)5.84  5.61  10.17  8.11  14.89  
   EV/CE(x)0.64  0.68  1.04  1.22  2.49  
   M Cap / Sales1.24  1.25  2.19  2.35  4.35  
Growth Ratio          
   Net Sales Growth(%)-5.97  36.70  5.33  3.60  43.20  
   Core EBITDA Growth(%)-0.64  27.92  -19.17  6.40  29.61  
   EBIT Growth(%)-3.81  34.62  -24.33  4.20  31.32  
   PAT Growth(%)-7.75  37.28  -26.90  24.05  30.55  
   EPS Growth(%)-8.18  36.58  -26.90  24.05  30.55  
Financial Stability Ratios          
   Total Debt/Equity(x)0.08  0.10  0.12  0.13  0.12  
   Current Ratio(x)4.76  4.11  4.63  5.12  6.28  
   Quick Ratio(x)4.27  3.64  4.06  4.64  5.69  
   Interest Cover(x)12.50  30.23  16.40  19.38  39.08  
   Total Debt/Mcap(x)0.10  0.11  0.09  0.08  0.04